Tirzepatide significantly reduced the number of breathing interruptions during sleep a key measure of disease severity for clinically obese people living with moderate-to-severe obstructive sleep apnea, according to the results of two clinical trials published in the New England Journal of Medicine
Egan AG, Blind E, Dunder K, de Graeff PA, Hummer BT, Bourcier T, et al
Telehealth Providers offering FDA-Approved Medications Stick With FDA-Approved GLP-1s With the FDA officially banning compounded semaglutide and tirzepatide, the safest and most legal path forward is to stick with name-brand GLP-1 medications like Ozempic, Wegovy, Zepbound and Mounjaro
While human data is more limited, case reports from 2025-2026 suggest similar benefits in clinical practice, with women reporting improved mobility and reduced pain during menstruation